Investors

Latest News

SYGNIS AG announces completion of relocation of its Expedeon unit to allow for expansion

October 18th, 2017

Move forms part of integration into SYGNIS Group Madrid, Spain and Heidelberg, Germany, 18 October 2017 – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced the completion of the relocation of its subsidiary company, Expedeon, into the Company’s existing facilities in Cambridge, UK. The relocation follows the recent acquisition of Expedeon by SYGNIS…

View

October 18th, 2017

18 October 2017 SYGNIS AG announces completion of relocation of its Expedeon unit to allow for expansion   Move forms part of integration into SYGNIS Group Madrid, Spain and Heidelberg, Germany, 18 October 2017 – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced the completion of the relocation of its subsidiary company, Expedeon,…

View

Bioconjugation specialist Expedeon acquired by SYGNIS AG

June 26th, 2017

Innova CEO and CSO Dr. Nick Gee becomes Chief Technical Officer of SYGNIS Madrid, Spain, Heidelberg, Germany, and Cambridge, UK, 26th June 2017: Expedeon (Innova), a specialist provider of bioconjugation products and services, has announced it has been fully acquired by Sygnis AG, for EUR 8 million in cash and 3.5 million in shares. Innova’s…

View

TTP plc and Expedeon extend partnership to develop rapid point-of-care diagnostics

June 13th, 2017

Innova to continue to provide custom bioconjugation services to support TTP’s Desktop Biology initiative Cambridge, UK, 13 June 2017: TTP plc, Europe’s leading technology and product development company, today announces its ongoing partnership with Expedeon (Innova), a specialist provider of bioconjugation products and services, to enable its rapid point-of-care diagnostics development program. TTP’s Desktop Biology…

View

Expedeon introduces the FlexLISA kit

May 9th, 2017

Kit enables flexibility in development and optimization of ELISA assays Cambridge, UK, 09 May 2017: Expedeon (Innova), a specialist provider of bioconjugation products and services, today announced it has introduced the FlexLISA® kit, providing a flexible tool for development and optimization of sandwich ELISA assays. The FlexLISA kit allows researchers to covalently conjugate up to…

View

New! Alexa Fluor® 488 added to Lightning-Link® range

May 3rd, 2017

Expedeon adds Alexa Fluor® 488 to Lightning-Link® range of antibody labeling kits Enables easy, fast labeling of primary antibodies or proteins with Alexa Fluor 488 Cambridge, UK, 03 May 2017: Expedeon (Innova), a specialist provider of bioconjugation products and services, today announced it has added Alexa Fluor® 488, one of the most popular fluorescent labels…

View

Expedeon Introduces Biotin Check&Go! Kit

April 4th, 2017

Expedeon introduces Biotin Check&Go! Kit for confirming successful antibody-biotin conjugation Cambridge, UK, 04 April 2017: Expedeon (Innova), a specialist provider of bioconjugation products and services, today announced the launch of the Biotin Check&Go! Kit, which sits alongside its recently launched Conjugate Check&Go! Kit and is the Company’s second lateral flow product specific to antibody labeling….

View

Expedeon initiates monthly charity donation program

March 13th, 2017

Portion of profits to be assigned to charitable organizations following a successful 2016 Cambridge, UK, 13 March 2017: Expedeon (Innova), a specialist provider of bioconjugation products and services, today announces the initiation of its charity donation program, following a highly successful year in 2016. The Cambridge, UK based company will donate a portion of its…

View

Expedeon Introduces Magnetic Conjugation Kit

February 21st, 2017

New kit enables covalent conjugation of antibodies and proteins to magnetic particles Cambridge, UK, 21 February 2017: Expedeon (Innova), a specialist provider of bioconjugation products and services, today announced the launch of its Magnetic Conjugation Kit, the newest addition to the company’s range of particle conjugation technologies. The new kit allows researchers to covalently conjugate…

View

Expedeon Introduces the Europium conjugation kit

January 31st, 2017

New kit enables rapid generation of Eu bead conjugates for high sensitivity assays Cambridge, UK, 31 January 2017: Expedeon (Innova), a specialist provider of bioconjugation products and services, today announced the launch of its europium bead conjugation kit, the latest addition to its range of particle technologies. Europium conjugates provide much higher sensitivity when compared…

View

Expedeon introduces the Conjugate Check&Go! Kit for confirming successful conjugation

January 10th, 2017

Cambridge, UK, 10 January 2017: Expedeon (Innova), a specialist provider of bioconjugation products and services, today announced the launch of the Conjugate Check&Go! Kit, the company’s first lateral flow product specific to antibody labeling. The new kit allows scientists to confirm, in one easy step, whether an antibody has been successfully conjugated before moving on…

View

Expedeon Introduces the AbPure Magnetic Purification System

September 19th, 2016

Unique antibody purification system compatible with any conjugation technology Cambridge, UK, 19 September 2016: Expedeon (Innova), a specialist provider of bioconjugation products and services, today announced the launch of the AbPure™ Magnetic Purification system. The system is based on Protein A Magnetic Beads, which have a high affinity for IgG molecules and allow scientists to…

View